EZH2 and cancer: The enzyme has been found to be overexpressed in wide varieties of cancer, such as prostate, liver, gastric, breast, bladder, lung, and pancreatic cancers [129–135] with literature precedents ascertaining the role of EZH2 in augmenting the development and progression of cancer.